Grapheal wins CES 2022 Innovation Award

Grapheal has received an award for its graphene-enabled products at CES 2022.

Graphene Flagship Associated Member Grapheal has won the “Best in Innovation” Award from the Consumer Electronics Show (CES), considered the world’s most influential technology event. “We’re thrilled to receive this honor,” says Vincent Bochiat, CEO and co-founder of Grapheal. The company develops graphene-enabled technologies for the healthcare and medtech sectors.

New graphene-based neural probes improve detection of epileptic brain signals

Researchers the UK and Spain have demonstrated that tiny graphene neural probes can be used safely to improve our understanding of the causes of epilepsy.

The graphene depth neural probe (gDNP) consists of a millimeter-long linear array of micro-transistors imbedded in a micrometer-thin polymeric flexible substrate. The transistors were developed by a collaboration between The University of Manchester’s Neuromedicine Lab and UCL’s Institute of Neurology along with their Graphene Flagship partners.

Researchers develop graphene-biosensors for brain machine interfaces

Researchers at the University of Technology Sydney (UTS) have developed a novel graphene-based biosensor, set to drive new innovations in brain-controlled robotics.

The biosensor adheres to the skin of the face and head in order to detect electrical signals being sent by the brain. These signals can be translated into commands to control autonomous robotic systems. The sensor, made of epitaxial graphene grown onto a silicon carbide on silicon substrate, overcomes the major challenges of corrosion, durability and skin-contact resistance.

Graphenea certified for medical device components

This is a sponsored post by Graphenea

Graphenea has obtained ISO 13485 certification for manufacturing medical device components. The certification relates to the GFET product line and the Graphene Foundry service.

Graphenea, graphene FETs (GFETs) photo

The ISO standard is an important certification needed for the commercialization of medical applications of graphene, in particular non-implantable biosensors. Graphenea obtained certification for the entire process chain, including raw materials, design, development, manufacture and sale. The certificate also applies to facilities, quality management, tracing, and data analysis. The ISO certificate was issued after an independent audit by SGS.

GraphWear closes $20.5M Series B for a needle-free, graphene-powered glucose monitor

Graphwear, a startup developing graphene-based needle-free approaches to glucose monitoring, recently closed a $20.5 million Series B round. GraphWear is developing a skin-surface-level wearable made of graphene. The sensor is small, about the size of an Apple Watch — but the key piece of technology is actually housed on the bottom. It’s a thin slice of graphene that fits onto the back of the watch, or onto a sticker that can be worn on the abdomen.

Graphwear raises $20 million to promote graphene-based glucose sensors imageImage by Graphwear

This Series B round will be focused on helping the company build upon previous validation studies of the wearable, completing a pivotal trial and submitting for FDA clearance. The round was led by Mayfield, with participation from MissionBio Capital, Builders VC and VSC Ventures.